BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 35513835)

  • 1. EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression.
    Yang M; Hu H; Wu S; Ding J; Yin B; Huang B; Li F; Guo X; Han L
    J Exp Clin Cancer Res; 2022 May; 41(1):165. PubMed ID: 35513835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. hsa_circ_0101119 facilitates the progression of cervical cancer via an interaction with EIF4A3 to inhibit TCEAL6 expression.
    Sui X; Wang Y; Liu H
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway.
    Jiang Z; Tai Q; Xie X; Hou Z; Liu W; Yu Z; Liang Z; Chen S
    J Exp Clin Cancer Res; 2021 Jul; 40(1):227. PubMed ID: 34253241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
    Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
    J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.
    Liu Y; Song J; Zhang H; Liao Z; Liu F; Su C; Wang W; Han M; Zhang L; Zhu H; Zhang Z; Liang H; Zhang L; Zhang B; Chen X
    J Exp Clin Cancer Res; 2022 May; 41(1):164. PubMed ID: 35509064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EIF4A3-regulated hsa_circ_0001445 can inhibit the progression of laryngeal squamous cell carcinoma via hsa-miR-432-5p-dependent up-regulation of RGMA expression.
    Yu M; Cao H; Yang J; Liu T; Gao J; Wang B
    Cell Cycle; 2023 Sep; 22(18):2038-2056. PubMed ID: 37902305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.
    Yuan LX; Luo M; Liu RY; Wang HX; Ju LL; Wang F; Cao YL; Wang ZC; Chen L
    BMC Cancer; 2024 Feb; 24(1):239. PubMed ID: 38383334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis.
    Zhang M; Sun Y; Xu H; Shi Y; Shen R; Teng F; Xu J; Jia X
    Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):574-586. PubMed ID: 37057923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circ-SIRT1 Promotes Colorectal Cancer Proliferation and EMT by Recruiting and Binding to eIF4A3.
    Wang X; Liu S; Xu B; Liu Y; Kong P; Li C; Li B
    Anal Cell Pathol (Amst); 2021; 2021():5739769. PubMed ID: 34660182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
    Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
    Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR-1343-3p/Bcl-3 axis through TGFβ/Smad3/EMT signaling.
    Ge P; Chen X; Liu J; Jing R; Zhang X; Li H
    Mol Carcinog; 2023 Jul; 62(7):1073-1085. PubMed ID: 37132942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis.
    Huang X; Tan W; Liu Z; Fu X; Li Z; Lai S; Li Q; Zhong X; Qu F; Zhang H; Li H
    Life Sci; 2023 Jul; 324():121745. PubMed ID: 37127184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance.
    Wei W; Liu K; Huang X; Tian S; Wang H; Zhang C; Ye J; Dong Y; An Z; Ma X; Wang B; Huang Y; Zhang X
    J Exp Clin Cancer Res; 2024 Jan; 43(1):2. PubMed ID: 38163881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment.
    Song J; Liu Q; Han L; Song T; Huang S; Zhang X; He Q; Liang C; Zhu S; Xiong B
    J Exp Clin Cancer Res; 2023 Nov; 42(1):319. PubMed ID: 38008713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
    Xu YJ; Yu H; Liu GX
    J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_001988 attenuates GC progression in vitro and in vivo via sponging miR-197-3p.
    Sun D; Wang G; Xiao C; Xin Y
    J Cell Physiol; 2021 Jan; 236(1):612-624. PubMed ID: 32592202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
    Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
    Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.